Decoy Therapeutics Inc
(DCOY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 895 | 966 | 1,719 | 1,489 | 1,007 |
| Operating Income | -895 | -966 | -1,719 | -1,489 | -1,007 |
| Other Income | 22 | 8 | 9 | 25 | 34 |
| Pre-tax Income | -874 | -958 | -1,710 | -1,464 | -972 |
| Net Income Continuous | -874 | -958 | -1,710 | -1,464 | -972 |
| Net Income | $-874 | $-958 | $-1,710 | $-1,464 | $-972 |
| EPS Basic Total Ops | -1.81 | -6.75 | -15.44 | 9.13 | -11.38 |
| EPS Basic Continuous Ops | -1.81 | -6.76 | -15.40 | 9.11 | -11.38 |
| EPS Diluted Total Ops | -1.81 | -6.75 | -15.44 | 9.13 | -11.38 |
| EPS Diluted Continuous Ops | -1.81 | -6.76 | -15.40 | 9.11 | -11.38 |
| EPS Diluted Before Non-Recurring Items | -1.81 | -6.75 | -15.44 | -9.90 | -11.39 |
| EBITDA(a) | $-894 | $-965 | $-1,718 | $-1,488 | $-1,005 |